An extract from tomato seeds has been found to be a potential alternative to aspirin in preventing heart attacks and strokes. A tomato derivative called Fruitflow, derived from the gelatine that surrounds tomato seeds, is apparently effective in reducing the risk of blood clotting.
Scientists at Aberdeen's Rowett Institute said the results of the latest trials were "statistically significant".
Provexis, a spin-off company of the research institute, which manufactures Fruitflow, has released its findings after comparing the effects of Fruitflow and aspirin over a seven-month period using 43 people.
"We are delighted with the results of this latest human trial, which highlights the substantial effect that Fruitflow can have, without the associated side effects known to occur with aspirin," the Scotsman quoted chief executive Stephen Moon as saying.
He added, "We have already announced intent to enter into an agreement with DSM Nutritional Products, the world's leading supplier of vitamins, carotenoids and other fine chemicals to feed, food, pharmaceutical and personal care industries."
No ill effects were observed even when Fruitflow and aspirin were taken together. The drawbacks of aspirin are that it increases risk of ulcers and stomach bleeding.
Comments